Navigation Links
Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007

iuretics; and -- the absence of treatment failure. Treatment failure was defined as: -- death; -- readmission to the hospital for heart failure within seven days of the first dose of KW-3902 or placebo; -- worsening of heart failure; or -- worsening renal function.

Patients treated with 30 milligrams of KW-3902 showed higher rates of treatment success and lower rates of treatment failure compared to the placebo group.

The pilot study also showed that 24-hours after treatment, self-reported marked or moderate improvement in dyspnea was observed in 66 percent of the patients who received the 30 milligram dose of KW-3902 as compared to 51 percent in the placebo group.

There were no statistical differences or trends in adverse events observed in the pilot study. The results of the study confirmed that 30 milligrams of KW-3902 is an appropriate dose for NovaCardia's two 600-patient pivotal Phase 3 trials, PROTECT 1 and PROTECT 2, which are currently enrolling participants in the United States, Canada, Europe, Israel and Russia.

KW-3902 is believed to block adenosine-mediated constriction of blood flow to the kidneys and inhibit reabsorption of salt and water by the kidney, thereby increasing urine volume and maintaining renal function in patients with CHF. As renal function deteriorates in patients with CHF, higher doses of diuretics are required in order to reduce fluid overload.

Multiple studies have demonstrated that renal dysfunction is a strong independent predictor of worse short- and long-term outcomes in patients with CHF. In the NovaCardia pilot study, the 30 milligram dose of KW-3902 also showed a positive effect on patients' renal function over time compared to placebo. Although KW-3902 was administered for only the first three days of the trial, an apparent dose response was seen in serum creatinine, a commonly used marker of worsening renal function, at day 14. The study showed no
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:12/22/2014)... Dec. 22, 2014 NxStage Medical, Inc. (NASDAQ: ... innovative dialysis products, announced today that the U.S. ... System One™ to perform hemodialysis overnight while the ... nocturnal hemodialysis. NxStage,s® System One is the first ... for this indication. Home nocturnal ...
(Date:12/22/2014)... Dec. 22, 2014   TRU-D SmartUVC LLC, ... disinfection robot, announced today that the General Services Administration ... November 2019.   This newly formed agreement ... levels of government purchasers, including Department of Veteran Affairs ... Homeland Security contacts purchasing solutions for the Ebola effort ...
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a global leader ... today announced it will participate in the 33 rd ... in San Francisco . ... speak at 11:00 AM Pacific Time.  A live audio webcast ... Investor Relations link on the Cyberonics home page at ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... Conn., Dec. 9, 2010 Boehringer Ingelheim Pharmaceuticals, Inc. ... the phase IIb/III LUX-Lung 1 trial show that afatinib ... 1.0 month for placebo) in progression-free survival (PFS) in ... to have an epidermal growth factor receptor (EGFR) mutation.(1) ...
... 8, 2010 Dr. Richard Merkin, President and CEO, Heritage ... Bears with Liz Clayman and David Asman revealing HPN,s new ... hospital health care costs. "We want in on ... she introduced Dr. Merkin. The HPN Health Prize ...
Cached Medicine Technology:New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 2New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 3New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 4New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 5Dr. Richard Merkin, President and CEO, Heritage Provider Network, Featured on Fox Business News, Bulls and Bears with Liz Clayman and David Asman, Revealing Challenge of $3 Million HPN Health Prize, Saving $30 Billion in Health Care Costs 2Dr. Richard Merkin, President and CEO, Heritage Provider Network, Featured on Fox Business News, Bulls and Bears with Liz Clayman and David Asman, Revealing Challenge of $3 Million HPN Health Prize, Saving $30 Billion in Health Care Costs 3
(Date:12/25/2014)... updated its blog to provide professional shopping tips on wedding and ... LunaDress.co.uk come with big discounts, up to 80 percent off. , ... to be a most exciting memory and can show off a ... a wedding. On the updated fashion blog, ladies can now find ... day . , Going out with friends to a party is ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- Overeating is common during the ... in moderation, an expert says. "Don,t arrive at a ... if you know you,ll be attending a party, but deprivation ... lead dietitian at Northern Westchester Hospital in Mount Kisco, N.Y., ... eat healthy during the day and even to have a ...
(Date:12/25/2014)... December 25, 2014 AngelWeddingDress.com tries its ... the online realm. Today, the business has introduced its ... site-wide prom dress promotion. , The new prom outfits ... and every dress lover. They are specially designed for ... prom dresses should visit its website before Jan. ...
(Date:12/25/2014)... Aliso Viejo, California (PRWEB) December 25, 2014 ... the release of ProFire 5k. A fully customizable business ... X . , “Adding the ProFire 5k business tool, ... style” Said Christina Austin, CEO of Pixel Film Studios. ... the look and style to add professionalism to a ...
(Date:12/25/2014)... 2014 Parker & Sons, Inc. an ... and affordable quality regarding heating, cooling and plumbing services ... 2014 by the “Queen of Clean” for impressive contractor ... impressive reputation over the years for providing outstanding quality ... of contractor services for both homeowners and businesses. Linda ...
Breaking Medicine News(10 mins):Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3
... has significantly contributed to progress in the fight against ... American Association for Cancer Research (AACR) at its 2008 ... San Diego, Calif. , A series of ... and largest professional organization representing cancer scientists from the ...
... Blue Shield companies designate Blue Distinction Centers,for Complex and ... of ongoing efforts,to raise the overall quality of healthcare ... expanding the Blue Distinction(R),designation., Today, Blue Cross and ... Blue Distinction Centers for Complex and Rare Cancers across ...
... York Stock Exchange Bell-Ringing, Shafallah Center Celebration and ... Web, Highlight Global Awareness Initiative, NEW YORK, March ... today announced a series of international,events to mark the ... effort to heighten awareness about a disorder,affecting millions of ...
... EaglePicher,Medical Power, a leading supplier of batteries ... Joseph (Joe) Marotta has,joined the company as vice ... position, Mr. Marotta will be responsible for the ... customer,development initiatives. EaglePicher,s medical division has seen tremendous,growth ...
... VALENCIA, Calif., March 11 TriMed, Inc., a ... has,announced that the United States Court of Appeals ... court,s summary judgment in its patent infringement,suit against ... Stryker,s accused device contains "precisely the same structure",shown ...
... 11 InforMedix Holdings,Inc. (OTC Bulletin Board: ... has engaged,Murdock Capital Partners to provide Capital ... in New York City, is a 16 ... advice, counsel, and assistance,regarding financial matters, including ...
Cached Medicine News:Health News:Leading researchers honored for progress in cancer prevention, detection and treatment 2Health News:Leading researchers honored for progress in cancer prevention, detection and treatment 3Health News:Leading researchers honored for progress in cancer prevention, detection and treatment 4Health News:Leading researchers honored for progress in cancer prevention, detection and treatment 5Health News:Leading researchers honored for progress in cancer prevention, detection and treatment 6Health News:Leading researchers honored for progress in cancer prevention, detection and treatment 7Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 2Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 3Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 4Health News:Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2 2Health News:Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2 3Health News:Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2 4Health News:EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing 2Health News:Court of Appeals Reverses Lower Court Decision in Favor of TriMed, Inc. Patent Infringement Case 2Health News:InforMedix Retains Murdock Capital Partners 2Health News:InforMedix Retains Murdock Capital Partners 3Health News:InforMedix Retains Murdock Capital Partners 4
... designed to address customer requests for another ... even wider range of clinical applications in ... flow imaging with super-high frame rates to ... a wealth of technological innovations that enhance ...
... In the Innova™ 4100, the ... X-ray system for angiographic imaging, ... piece, non tiled Digital Detector ... reliably provide high resolution imaging ...
... you perform exams from cardiac to angio. ... no compromises. An ideal 31 centimeters square, ... of cardiovascular and interventional imaging. With a ... variety of vascular and interventional procedures. The ...
... vasopressin (AVP), also known as Antidiurectic Hormone ... is transported via exonal flow to the ... AVP secretion is regulated by changes in ... respond to alterations in blood volume or ...
Medicine Products: